abstract |
A pharmaceutical composition for treating free radical-induced diseases or syndromes, comprising: an effective amount of compound: F(-X)m wherein, F is a fullerene nucleus; each X is independently -OH, -(CH2)n-SO3H, or the metal salt of -(CH2)n-SO3<SP>-</SP>, wherein, each n is independently an integer of from 2 to 50; and m is an integer of from 2 to 40; and a pharmaceutically acceptable vehicle. |